{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:09:25Z","timestamp":1789758565377,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00335-026-10277-6","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:20:25Z","timestamp":1789755625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP38 promotes breast cancer immune evasion and malignant progression by deubiquitinating and stabilizing PD-L1"],"prefix":"10.1007","volume":"37","author":[{"given":"Dongqin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"5","key":"10277_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2019.08.002","volume":"35","author":"M Abbott","year":"2019","unstructured":"Abbott M, Ustoyev Y (2019) Cancer and the immune system: the history and background of immunotherapy. Semin Oncol Nurs 35(5):150923. https:\/\/doi.org\/10.1016\/j.soncn.2019.08.002","journal-title":"Semin Oncol Nurs"},{"issue":"6","key":"10277_CR2","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3892\/or.2012.2018","volume":"28","author":"A Armakolas","year":"2012","unstructured":"Armakolas A, Stathopoulos GP, Nezos A, Theos A, Stathaki M, Koutsilieris M (2012) Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients. Oncol Rep 28(6):2255\u20132263. https:\/\/doi.org\/10.3892\/or.2012.2018","journal-title":"Oncol Rep"},{"issue":"1","key":"10277_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1257452","volume":"6","author":"L Buisseret","year":"2017","unstructured":"Buisseret L, Garaud S, de Wind A, Van den Eynden G, Boisson A, Solinas C, Gu-Trantien C, Naveaux C, Lodewyckx JN, Duvillier H, Craciun L, Veys I, Larsimont D, Piccart-Gebhart M, Stagg J, Sotiriou C, Willard-Gallo K (2017) Tumor-infiltrating lymphocyte composition, organization and PD-1\/PD-L1 expression are linked in breast cancer. Oncoimmunology 6(1):e1257452. https:\/\/doi.org\/10.1080\/2162402x.2016.1257452","journal-title":"Oncoimmunology"},{"issue":"11","key":"10277_CR4","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1084\/jem.20172026","volume":"215","author":"S Chen","year":"2018","unstructured":"Chen S, Yun F, Yao Y, Cao M, Zhang Y, Wang J, Song X, Qian Y (2018) USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein. J Exp Med 215(11):2850\u20132867. https:\/\/doi.org\/10.1084\/jem.20172026","journal-title":"J Exp Med"},{"issue":"Pt 2","key":"10277_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.149611","volume":"341","author":"X Chu","year":"2026","unstructured":"Chu X, Wang W (2026) USP38 regulates autophagy-dependent ferroptosis by deubiquitinating CTNNB1 in melanoma. Int J Biol Macromol 341(Pt 2):149611. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149611","journal-title":"Int J Biol Macromol"},{"key":"10277_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004874","author":"G Deng","year":"2022","unstructured":"Deng G, Zhou L, Wang B, Sun X, Zhang Q, Chen H, Wan N, Ye H, Wu X, Sun D, Sun Y, Cheng H (2022) Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-004874","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10277_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D (2023) Deubiquitinases in cancer. Nat Rev Cancer 23(12):842\u2013862. https:\/\/doi.org\/10.1038\/s41568-023-00633-y","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10277_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","volume":"24","author":"I Dikic","year":"2023","unstructured":"Dikic I, Schulman BA (2023) An expanded lexicon for the ubiquitin code. Nat Rev Mol Cell Biol 24(4):273\u2013287. https:\/\/doi.org\/10.1038\/s41580-022-00543-1","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10277_CR9","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K (2019) CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol 234(6):8509\u20138521. https:\/\/doi.org\/10.1002\/jcp.27782","journal-title":"J Cell Physiol"},{"key":"10277_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010224","author":"KE Gilligan","year":"2020","unstructured":"Gilligan KE, Dwyer RM (2020) Extracellular vesicles for cancer therapy: impact of host immune response. Cells. https:\/\/doi.org\/10.3390\/cells9010224","journal-title":"Cells"},{"issue":"11","key":"10277_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","volume":"11","author":"Q Gou","year":"2020","unstructured":"Gou Q, Dong C, Xu H, Khan B, Jin J, Liu Q, Shi J, Hou Y (2020) PD-L1 degradation pathway and immunotherapy for cancer. Cell Death Dis 11(11):955. https:\/\/doi.org\/10.1038\/s41419-020-03140-2","journal-title":"Cell Death Dis"},{"issue":"1","key":"10277_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s10020-025-01235-0","volume":"31","author":"JY Han","year":"2025","unstructured":"Han JY, Rhee WJ, Shin JS (2025) Cytoplasmic HMGB1 promotes the activation of JAK2-STAT3 signaling and PD-L1 expression in breast cancer. Mol Med 31(1):197. https:\/\/doi.org\/10.1186\/s10020-025-01235-0","journal-title":"Mol Med"},{"issue":"1","key":"10277_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-024-01649-z","volume":"17","author":"NK Heater","year":"2024","unstructured":"Heater NK, Warrior S, Lu J (2024) Current and future immunotherapy for breast cancer. J Hematol Oncol 17(1):131. https:\/\/doi.org\/10.1186\/s13045-024-01649-z","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10277_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5114\/fn.2021.112571","volume":"59","author":"T Hu","year":"2021","unstructured":"Hu T, Wang KN, LingHu HR (2021) USP38 might be a new therapeutic target for glioma via regulation of cancer cell metastasis. Folia Neuropathol 59(4):359\u2013371. https:\/\/doi.org\/10.5114\/fn.2021.112571","journal-title":"Folia Neuropathol"},{"issue":"10","key":"10277_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010366","volume":"18","author":"J Huang","year":"2022","unstructured":"Huang J, Zhou W, Hao C, He Q, Tu X (2022) The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer. PLoS Genet 18(10):e1010366. https:\/\/doi.org\/10.1371\/journal.pgen.1010366","journal-title":"PLoS Genet"},{"issue":"5","key":"10277_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21(5):298\u2013312. https:\/\/doi.org\/10.1038\/s41568-021-00339-z","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"10277_CR17","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2174\/0929867324666170804143706","volume":"26","author":"B Li","year":"2019","unstructured":"Li B, Chan HL, Chen P (2019) Immune Checkpoint Inhibitors: Basics and Challenges. Curr Med Chem 26(17):3009\u20133025. https:\/\/doi.org\/10.2174\/0929867324666170804143706","journal-title":"Curr Med Chem"},{"key":"10277_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1612723","volume":"16","author":"J Li","year":"2025","unstructured":"Li J, Zhong J, Ye J, Xiang Y, Yi Q, Zhu G, Deng S, Wang X (2025) USP38: an important regulatory factor in tumor malignant progression. Front Immunol 16:1612723. https:\/\/doi.org\/10.3389\/fimmu.2025.1612723","journal-title":"Front Immunol"},{"issue":"1","key":"10277_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, Lu B, Fan Y, Liu Z, Chen X, Jia X, Dong Z, Liu K (2024) Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer 23(1):148. https:\/\/doi.org\/10.1186\/s12943-024-02046-3","journal-title":"Mol Cancer"},{"issue":"2","key":"10277_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.mcna.2022.10.007","volume":"107","author":"E Michaels","year":"2023","unstructured":"Michaels E, Worthington RO, Rusiecki J (2023) Breast Cancer: Risk Assessment, Screening, and Primary Prevention. Med Clin North Am 107(2):271\u2013284. https:\/\/doi.org\/10.1016\/j.mcna.2022.10.007","journal-title":"Med Clin North Am"},{"issue":"36","key":"10277_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303807","volume":"10","author":"J Ren","year":"2023","unstructured":"Ren J, Yu P, Liu S, Li R, Niu X, Chen Y, Zhang Z, Zhou F, Zhang L (2023) Deubiquitylating enzymes in cancer and immunity. Adv Sci (Weinh) 10(36):e2303807. https:\/\/doi.org\/10.1002\/advs.202303807","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"10277_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","volume":"25","author":"M Roerden","year":"2025","unstructured":"Roerden M, Spranger S (2025) Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat Rev Immunol 25(5):353\u2013369. https:\/\/doi.org\/10.1038\/s41577-024-01111-8","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10277_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-immunol-083122-040929","volume":"42","author":"Z Steier","year":"2024","unstructured":"Steier Z, Kim EJY, Aylard DA, Robey EA (2024) The CD4 versus CD8 T cell fate decision: a multiomics-informed perspective. Annu Rev Immunol 42(1):235\u2013258. https:\/\/doi.org\/10.1146\/annurev-immunol-083122-040929","journal-title":"Annu Rev Immunol"},{"key":"10277_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1471-2466-14-187","volume":"14","author":"S Stepaniants","year":"2014","unstructured":"Stepaniants S, Wang IM, Boie Y, Mortimer J, Kennedy B, Elliott M, Hayashi S, Luo H, Wong J, Loy L, Coulter S, Roberts CJ, Hogg JC, Sin DD, O\u2019Neill G, Crackower M, Morris M, Par\u00e9 PD, Obeidat M (2014) Genes related to emphysema are enriched for ubiquitination pathways. BMC Pulm Med 14:187. https:\/\/doi.org\/10.1186\/1471-2466-14-187","journal-title":"BMC Pulm Med"},{"key":"10277_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1600-065X.2008.00611.x","volume":"222","author":"EM Tan","year":"2008","unstructured":"Tan EM, Zhang J (2008) Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev 222:328\u2013340. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00611.x","journal-title":"Immunol Rev"},{"key":"10277_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jare.2024.12.026","volume":"76","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang X, Chen Q, Wu H, Cao S, Zhao S, Li G, Wang J, Gong Y, Wang X, Pang D, Gao S (2025) FTO activates PD-L1 promotes immunosuppression in breast cancer via the m6A\/YTHDF3\/PDK1 axis under hypoxic conditions. J Adv Res 76:191\u2013206. https:\/\/doi.org\/10.1016\/j.jare.2024.12.026","journal-title":"J Adv Res"},{"issue":"12","key":"10277_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14715\/cmb\/2018.64.12.14","volume":"64","author":"W Xiaohua","year":"2018","unstructured":"Xiaohua W, Hongxia X, Rong D, Pingping W, Xing H, Yichao Z, Cheng C (2018) SMAR1 promotes immune escape of Tri-negative Breast Cancer through a mechanism involving T-bet\/PD-1 axis. Cell Mol Biol (Noisy-le-grand) 64(12):70\u201375","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1","key":"10277_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K (2022) Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer 21(1):28. https:\/\/doi.org\/10.1186\/s12943-021-01489-2","journal-title":"Mol Cancer"},{"key":"10277_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010151","author":"Y Yu","year":"2025","unstructured":"Yu Y, Sun R, Hu F, Ding Z, Li X, Han J, Liang L, Wang T, Xi G, Dong X, Li Y, Zhao X, Zhang D (2025) Hypoxia upregulates the expression of PD-L1 via NPM1 in breast cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-010151","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10277_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7314\/apjcp.2014.15.1.265","volume":"15","author":"CH Yuan","year":"2014","unstructured":"Yuan CH, Yang XQ, Zhu CL, Liu SP, Wang BC, Wang FB (2014) Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8\u2009+\u2009T cells with induction of IFN-gamma in a murine breast cancer model. Asian Pac J Cancer Prev 15(1):265\u2013271. https:\/\/doi.org\/10.7314\/apjcp.2014.15.1.265","journal-title":"Asian Pac J Cancer Prev"},{"key":"10277_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032542","author":"A Zannetti","year":"2023","unstructured":"Zannetti A (2023) Breast cancer: from pathophysiology to novel therapeutic approaches 2.0. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032542","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10277_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-0234-z","volume":"9","author":"W Zhan","year":"2020","unstructured":"Zhan W, Liao X, Liu J, Tian T, Yu L, Li R (2020) USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3. Oncogenesis 9(5):48. https:\/\/doi.org\/10.1038\/s41389-020-0234-z","journal-title":"Oncogenesis"},{"issue":"16","key":"10277_CR33","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41388-024-02985-7","volume":"43","author":"T Zhang","year":"2024","unstructured":"Zhang T, Su F, Wang B, Liu L, Lu Y, Su H, Ling R, Yue P, Dai H, Yang T, Yang J, Chen R, Wu R, Zhu K, Zhao D, Hou X (2024) Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma. Oncogene 43(16):1190\u20131202. https:\/\/doi.org\/10.1038\/s41388-024-02985-7","journal-title":"Oncogene"},{"issue":"6","key":"10277_CR34","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41418-025-01462-2","volume":"32","author":"S Zhao","year":"2025","unstructured":"Zhao S, Liu X, Luo R, Jian Z, Xu C, Hou Y, Liu X, Zhang P (2025) USP38 functions as an oncoprotein by downregulating the p53 pathway through deubiquitination and stabilization of MDM2. Cell Death Differ 32(6):1128\u20131141. https:\/\/doi.org\/10.1038\/s41418-025-01462-2","journal-title":"Cell Death Differ"},{"key":"10277_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","volume":"86","author":"N Zheng","year":"2017","unstructured":"Zheng N, Shabek N (2017) Ubiquitin Ligases: Structure, Function, and Regulation. Annu Rev Biochem 86:129\u2013157. https:\/\/doi.org\/10.1146\/annurev-biochem-060815-014922","journal-title":"Annu Rev Biochem"},{"key":"10277_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009082","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wu C, Wang X, Pan N, Sun X, Chen B, Zheng S, Wei Y, Chen J, Wu Y, Zhu F, Chen J, Chen H, Wang LX (2024) Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-009082","journal-title":"J Immunother Cancer"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10277-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-026-10277-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10277-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:20:26Z","timestamp":1789755626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-026-10277-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10277"],"URL":"https:\/\/doi.org\/10.1007\/s00335-026-10277-6","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of The Yancheng Clinical College of Xuzhou Medical University (The First People\u2019s Hospital of Yancheng). All participants were provided with written informed consent at the time of recruitment, and all experiments involving human tissue specimens comply with the\n                      Declaration of Helsinki\n                      . Animal studies were performed in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"107"}}